1 completed, 1 terminated. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Terminated 1 |
Follow Fred Lublin: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Combination Therapy in Patients With Relapsing-Remitting Multiple Sclerosis (MS)CombiRx Interferon beta 1-a, glatiramer acetate, placebo - Relapsing Remitting Multiple Sclerosis | Phase 3 | Completed | Fred Lublin | 1008 | 2005-01-01 | 2014-04-03 |
| Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks megadose oral methylprednisolone, IV methylprednisolone - Multiple Sclerosis | Phase 3 | Terminated | Fred Lublin | 16 | 2003-09-01 | 2017-05-18 |
Multiple Sclerosis (2) · Autoimmune Diseases (1) · Multiple Sclerosis, Relapsing-Remitting (1)
Glatiramer Acetate (1) · Interferon beta-1a (1) · Methylprednisolone (1)
United States (2) · Canada (1)
PMID 23424159, PMID 24686106, PMID 31289819, PMID 32554770, PMID 34376508, PMID 34433679, PMID 34695274, PMID 34759712, PMID 34927308, PMID 36382118, PMID 37119208, PMID 37830451
U01NS045719 (1)